SA
Log In
ANRO
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Buy
8 analysts·Limited coverage
72
Score
7 Buy (88%)1 Hold (13%)0 Sell (-1%)
Rating Breakdown
Strong Buy
00%
Buy
788%
Hold
113%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$28.00
+11.2%
Consensus
$31.50
+25.0%
Bull
$35.00
+38.9%
12-Month Target Range8 analysts
$28.00$31.50$35.00
Current $25.19Consensus
Current Price
$25.19
Upside to Consensus
$6.31

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev—
EPS—
FY2028
Rev—
EPS—
FY2029
Rev+402.06%
EPS—

Earnings Surprises

Recent Analyst Actions

Mar 16, 2026Jefferies
Alto Neuroscience (ANRO) PT Raised to $35 at Jefferies
Target:$35.00
+41.2%from $24.78
Feb 17, 2026BTIG
Alto Neuroscience price target raised to $28 from $27 at BTIG
Target:$28.00
+65.8%from $16.89
Oct 20, 2025Robert W. Baird
Alto Neuroscience price target raised to $16 from $10 at Baird
Target:$16.00
+44.6%from $11.07
Oct 23, 2024Robert W. Baird
Alto Neuroscience (ANRO) PT Lowered to $10 at Baird
Target:$10.00
-31.2%from $14.53
Jun 20, 2024Robert W. Baird
Baird on Alto Neuroscience (ANRO): 'Incrementally positive on Phase 2 CIAS initiation'
Target:$32.00
+188.0%from $11.11

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance